Clonidine extended-release oral tablet is a prescription medication used to treat attention deficit hyperactivity disorder (ADHD). Clonidine is available in various forms, some of which come in ...
Woburn, MA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today the availability of Javadin™ (clonidine hydrochloride) oral solution, the only FDA-approved, ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
Woburn, MA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Javadin™ (clonidine hydrochloride) oral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results